Sex steroids, carcinogenesis, and cancer progression

Annals of the New York Academy of Sciences

Volumn 1028, Issue , 2004, Pages 233-246

  Castagnetta, Luigi ^a,b   Granata, Orazia M ^b   Cocciadiferro, Letizia ^b   Saetta, Annalisa ^b   Polito, Lucia ^b   Bronte, Giuseppe ^a   Rizzo, Sergio ^a   Campisi, Ildegarda ^b   Agostara, Biagio ^c   Carruba, Giuseppe ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b Ospedale Oncologico M Ascoli   (Italy)

^c NONE

Author keywords

Breast cancer; Intratumor estrogens; Sex steroids

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; SEX HORMONE; STEROID RECEPTOR;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CONFERENCE PAPER; ENDOMETRIUM; HUMAN; HUMAN CELL; OXIDATION; PROSTATE; REDUCTION; STEROID METABOLISM;

EID: 20144369342     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1321.028     Document Type: Conference Paper

References (21)

1. CASTAGNETTA, L., G. PAPAROPOLI, A. TRAINA, et al. 1977. Human breast cancer: studies on urinary excretion of endogenous oestrogens and its changes after hormone treatment. In Prevention and Detection of Cancer. Part I. H. Nieburgs, Ed. 1: 627-636. Marcel Dekker. New York.
2. CASTAGNETTA, L., G. D'AGOSTINO, M. LO CASTO, et al. 1981. Breast cancer: a comparison of response to endocrine therapy and oestrogen excretion patterns including unusual metabolites. Br. J. Cancer 44: 670-674.
3. CASTAGNETTA, L., G. D'AGOSTINO, O.M. GRANATA, et al. 1983. Studies on estrogen status and estrogen hormone sensitivity in advanced endometrial cancer. In Steroids and Endometrial Cancer. M. Jasonni et al., Eds.: 233-236. Raven Press. New York.
4. CASTAGNETTA, L.A., O.M. GRANATA, M. LO CASTO, et al. 1991. Simple approach to measure metabolic pathways of steroids in living cells. J. Chromatogr. 572: 25-39.
5. CASTAGNETTA, L., O.M. GRANATA, L. POLITO, et al. 1994. Different conversion metabolic rates of testosterone are associated to hormone-sensitive status and -response of human prostate cancer cells. J. Steroid Biochem. Mol. Biol. 49: 351-357.
6. CASTAGNETTA, L.A., O.M. GRANATA, R. FARRUGGIO, et al. 1995. Oxidative and reductive pathways of estrogens in hormone responsive and non-responsive human breast cancer cells in vitro. J. Steroid Biochem. Mol. Biol. 53: 367-374.
7. CASTAGNETTA, L.A., A.M. MONTESANTI, O.M. GRANATA, et al. 1995. 17β-Hydroxysteroid dehydrogenase activity in endometrial cancer cells: different metabolic pathways of estradiol in hormone-responsive and non-responsive intact cells. J. Steroid Biochem. Mol. Biol. 55: 573-579.
8. CASTAGNETTA, L.A., O.M. GRANATA, A. TRAINA, et al. 2002. Tissue content of hydroxyestrogens in relation to survival of breast cancer patients. Clin. Cancer Res. 8: 3146-3155.
9. ROGAN, E.G., A.F. BADAWI, P.D. DEVANESAN, et al. 2003. Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis 24: 697-702.
10. PASQUALINI, J.R., C. GELLY & B.-L. NGUYEN. 1990. Metabolism and biological response of estrogen sulfates in hormone-dependent and hormone-independent mammary cancer cell lines. Ann. N.Y. Acad. Sci. 595: 106-116.
11. ADAMS, J.B., R. VRAHIMIS & N. PHILLIPS. 1992. Regulation of estrogen sulfotransferase by estrogen in MCF-7 human mammary cancer cells. Breast Cancer Res. Treat. 22: 157-161.
12. CASTAGNETTA, L., O.M. GRANATA, M. LO CASTO, et al. 1986. Estrone conversion rates by human endometrial cancer cell lines. J. Steroid Biochem. 25: 803-809.
13. MILLER, W.R. & J.S. O'NEILL. 1987. Mammary steroidogenesis: therapeutic implications. Nuclear Med. Biol. 14: 369-376.
14. ADAMS, J.B., N.S. PHILLIPS & R. HALL. 1988. Metabolic fate of estradiol in human mammary cancer cells in culture: estrogen sulfate formation and cooperativity exhibited by estrogen sulfotransferase. Mol. Cell. Endocrinol. 58: 231-242.
15. PASQUALINI, J., B. SCHATZ, C. VARIN & B. NGUYEN. 1992. Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer. J. Steroid Biochem. Mol. Biol. 41: 323-329.
16. CASTAGNETTA, L.A., O.M. GRANATA, F.P. ARCURI, et al. 1992. Gas chromatography/mass spectrometry of catechol estrogens. Steroids 57: 437-443.
17. CASTAGNETTA, L., S. D'AQUINO, F. LABRIE & H. BRADLOW, EDS. 1990. Steroid Formation, Degradation, and Action in Peripheral Tissues. Ann. NY Acad. Sci. 595.
18. LABRIE, F. 1991. Intracrinology. Mol. Cell. Endocrinol. 78: C113-C118.
19. LIEHR, J. 2000. Is estradiol a genotoxic mutagenic carcinogen? Endocr. Rev. 21: 40-54.
20. CAVALIERI, E., D. STACK, P. DEVANESAN, et al. 1997. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA 94: 10937-10942.
21. BRADLOW, H.L., R.J. HERSHCOPF, C.P. MARTUCCI & J. FISHMAN. 1985. Estradiol 16α-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc. Natl. Acad. Sci. USA 82: 6295-6299.